DZ2448A1 - Sel du dérivé d'acide de naphthyridine carboxylique. - Google Patents

Sel du dérivé d'acide de naphthyridine carboxylique.

Info

Publication number
DZ2448A1
DZ2448A1 DZ980058A DZ980058A DZ2448A1 DZ 2448 A1 DZ2448 A1 DZ 2448A1 DZ 980058 A DZ980058 A DZ 980058A DZ 980058 A DZ980058 A DZ 980058A DZ 2448 A1 DZ2448 A1 DZ 2448A1
Authority
DZ
Algeria
Prior art keywords
salt
carboxylic acid
acid derivative
naphthyridine carboxylic
naphthyridine
Prior art date
Application number
DZ980058A
Other languages
English (en)
French (fr)
Inventor
Ae Ri Kim
Jin Hwa Lee
Ki Sook Park
Jong Ryoo Choi
Tae Hee Lee
Jay Hyok Chang
Do Hyun Nam
Hoon Choi
Original Assignee
Lg Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemicals Ltd filed Critical Lg Chemicals Ltd
Application granted granted Critical
Publication of DZ2448A1 publication Critical patent/DZ2448A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DZ980058A 1997-03-21 1998-03-18 Sel du dérivé d'acide de naphthyridine carboxylique. DZ2448A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR19970009840 1997-03-21

Publications (1)

Publication Number Publication Date
DZ2448A1 true DZ2448A1 (fr) 2003-01-11

Family

ID=19500439

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980058A DZ2448A1 (fr) 1997-03-21 1998-03-18 Sel du dérivé d'acide de naphthyridine carboxylique.

Country Status (39)

Country Link
US (9) US7700617B2 (de)
EP (2) EP1179533B1 (de)
JP (3) JP3759962B2 (de)
KR (1) KR100266499B1 (de)
CN (1) CN1131229C (de)
AP (1) AP1331A (de)
AR (1) AR012125A1 (de)
AT (2) ATE257836T1 (de)
AU (1) AU726634B2 (de)
BG (1) BG63972B1 (de)
BR (1) BR9808290A (de)
CA (1) CA2283671C (de)
CZ (2) CZ288673B6 (de)
DE (2) DE69821147T2 (de)
DK (2) DK1179533T3 (de)
DZ (1) DZ2448A1 (de)
EA (1) EA001674B1 (de)
ES (2) ES2198697T3 (de)
HK (1) HK1026698A1 (de)
HU (2) HU227536B1 (de)
ID (1) ID22681A (de)
IL (2) IL131812A0 (de)
IN (1) IN188178B (de)
IS (2) IS2093B (de)
MA (1) MA24500A1 (de)
MY (1) MY137653A (de)
NO (1) NO312515B1 (de)
NZ (1) NZ337748A (de)
OA (1) OA11161A (de)
PE (1) PE67999A1 (de)
PL (1) PL191815B1 (de)
PT (2) PT1179533E (de)
SA (1) SA98181055B1 (de)
SI (2) SI0981527T1 (de)
SK (1) SK284107B6 (de)
TR (1) TR199902313T2 (de)
UA (1) UA56218C2 (de)
WO (1) WO1998042705A1 (de)
ZA (1) ZA982335B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
AU773490B2 (en) * 1999-03-19 2004-05-27 Abbott Gmbh & Co. Kg Treatment of osteoarthritis
US6262071B1 (en) 1999-06-29 2001-07-17 Smithkline Beecham Corporation Methods of use of antimicrobial compounds against pathogenic amycoplasma bacteria
US6331550B1 (en) 1999-06-29 2001-12-18 Smithkline Beecham Corporation Methods of use of quinolone compounds against anaerobic pathogenic bacteria
CA2282066C (en) 1999-06-29 2010-09-07 Smithkline Beecham Corporation Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteria
US6803376B1 (en) 1999-06-29 2004-10-12 Smithkline Beecham Corporation Method of use of quinolone compounds against pneumococcal and haemophilus bacteria
GB9920919D0 (en) * 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) * 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
JP2001097864A (ja) * 1999-09-24 2001-04-10 Smithkline Beecham Corp 呼吸管および尿路病原性細菌に対するフルオロキノリン化合物の使用方法
JP2001097863A (ja) * 1999-09-24 2001-04-10 Smithkline Beecham Corp 嫌気性病原菌に対するフルオロキノロン化合物の使用法
JP2001097891A (ja) * 1999-09-24 2001-04-10 Smithkline Beecham Corp 呼吸器系病原菌に対するフルオロキノロン化合物の使用法
GR1003520B (el) * 1999-09-22 2001-01-22 Smithkline Beecham Plc Μεθοδος χρησης ενωσεων φλουοροκινολονης εναντια σε νοσοκομειακα αρνητικα κατα gramμ παθογενων βακτηριδιων
EP1561465A3 (de) * 1999-09-22 2005-12-21 LG Life Sciences, Ltd. Verfahren zur Verwendung von fluorochinolonen Verbindungen gegen Bakterien
GR1003521B (el) * 1999-09-23 2001-01-22 Smithkline Beecham Plc Μεθοδοι χρησεως ενωσεων φλουοροκινολονης εναντια κατα gram θετικων παθογονων βακτηριδιων
KR20010091379A (ko) * 2000-03-15 2001-10-23 성재갑 7-(4-아미노메틸-3-옥심)피롤리딘 치환체를 갖는 퀴놀린카르복실산 유도체의 신규 제조방법
WO2003011450A1 (en) 2001-08-02 2003-02-13 Lg Life Sciences Limited Processes for the production of amino-protected derivatives of 4-aminomethylene-pyrrolidin-3-one and/or 4-aminomethylene-pyrrolidin-3-alkoxyimino derivatives and/or gemifloxacin or a salt thereof
ES2292844T3 (es) * 2001-11-30 2008-03-16 Lg Life Sciences Ltd. Utilizacion de gemifloxacina o sus sales con un antibiotico b-lactamico para la preparacion de medicamentos.
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
AR043880A1 (es) * 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
US7834027B2 (en) 2005-06-15 2010-11-16 Hetero Drugs Limited Gemifloxacin process and polymorphs
MX2008011376A (es) * 2006-03-07 2009-02-06 Wockhardt Ltd Profarmacos de acido benzoquinolizin-2-carboxilico.
WO2010001408A2 (en) * 2008-06-06 2010-01-07 Matrix Laboratories Ltd. Novel polymorphic forms of gemifloxacin mesylate
WO2010146594A1 (en) * 2009-06-16 2010-12-23 Hetero Research Foundation Novel polymorphs of gemifloxacin mesylate
EP2491921A1 (de) 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Die Aufrechthaltung der wasserfreien Form von Gemifloxacin
SI2820016T1 (sl) * 2012-02-27 2017-11-30 Bristol-Myers Squibb Company N-(5s,6s,9r)-5-amino-6-(2,3-difluorofenil)-6,7,8,9-tetrahidro-5h- ciklohepta (b)piridin-9-il-4-(2-okso-2, 3-dihidro-1h-imidazo(4,5-b) piridin-1-il) piperidin-1-karboksilat, hemisulfatna sol
CZ2016104A3 (cs) * 2016-02-24 2017-09-06 Zentiva, K.S. Krystalické modifikace solí methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}fenyl)amino](fenyl)methyliden}-2-oxo-2,3-dihydro-1H-indol-6-karboxylátu a způsoby jejich přípravy

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR223983A1 (es) 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
ES512969A0 (es) 1981-06-11 1983-02-16 Warner Lambert Co "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
IN162769B (de) 1984-11-13 1988-07-09 Kyorin Seiyaku Kk
NZ222047A (en) 1986-10-08 1991-01-29 Bristol Myers Co Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPH01100165A (ja) 1987-10-13 1989-04-18 Shionogi & Co Ltd オキシムまたはヒドロキシアミン誘導体系抗菌剤
US4920120A (en) 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
US4931446A (en) * 1988-03-23 1990-06-05 Abbott Laboratories Antimicrobial for in-vitro diagnostic kits
US5286723A (en) * 1988-08-31 1994-02-15 Daiichi Seiyaku Co., Ltd. Spiro compound
CA1336090C (en) * 1988-08-31 1995-06-27 Isao Hayakawa Spiro-substituted cyclic amines of quinolone derivatives
RU2049777C1 (ru) 1989-08-16 1995-12-10 Пфайзер Инк. Азабицикло-хинолон-карбоновые кислоты или их фармацевтически приемлемые кислотно-аддитивные соли и промежуточные продукты для их получения
US5276041A (en) 1991-11-08 1994-01-04 Kaken Pharmaceutical Co., Ltd. Oxime derivatives
WO1993025545A1 (en) 1992-06-09 1993-12-23 Korea Research Institute Of Chemical Technology Novel quinoline derivatives and processes for preparing the same
US5776944A (en) * 1994-06-16 1998-07-07 Lg Chemical Ltd. 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof
EP0688772B1 (de) * 1994-06-16 1999-05-06 LG Chemical Limited Chinolincarbonsäurederivate mit 7-(4-Amino-methyl-3-oxim)-pyrrolidin-Substituenten und Verfahren zu ihrer Herstellung
DE69531305T2 (de) 1994-10-20 2004-05-13 Wakunaga Seiyaku K.K. Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten
WO1996023775A1 (fr) 1995-01-30 1996-08-08 Wakunaga Seiyaku Kabushiki Kaisha Nouveaux derives d'acide pyridonecarboxylique ou de ses sels et agent antibacterien contenant ces derives en tant qu'ingredient actif
CA2223404C (en) 1995-06-06 2001-01-16 Thomas A. Morris Novel crystal form of anhydrous 7-(¬1.alpha., 5.alpha., 6.alpha.|-6-amino-3-azabicyclo¬3.1.0|hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt
US20020032216A1 (en) * 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
KR100286874B1 (ko) * 1998-03-04 2001-04-16 성재갑 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process

Also Published As

Publication number Publication date
SI1179533T1 (en) 2004-04-30
JP3759962B2 (ja) 2006-03-29
SA98181055B1 (ar) 2006-10-11
PL191815B1 (pl) 2006-07-31
ATE257836T1 (de) 2004-01-15
US7700617B2 (en) 2010-04-20
US20100240694A1 (en) 2010-09-23
IS2093B (is) 2006-04-12
ZA982335B (en) 1999-11-23
CA2283671A1 (en) 1998-10-01
BR9808290A (pt) 2000-05-16
JP2009051851A (ja) 2009-03-12
EA199900855A1 (ru) 2000-04-24
HUP0000728A3 (en) 2002-12-28
EP1179533A3 (de) 2002-03-20
ES2198697T3 (es) 2004-02-01
EP0981527B1 (de) 2003-05-07
HU0600401D0 (en) 2006-07-28
HU227536B1 (en) 2011-08-29
KR19980080504A (ko) 1998-11-25
EP1179533B1 (de) 2004-01-14
DE69821147T2 (de) 2004-11-11
EP1179533A2 (de) 2002-02-13
HUP0000728A2 (hu) 2000-09-28
WO1998042705A1 (en) 1998-10-01
JP4781614B2 (ja) 2011-09-28
SK123699A3 (en) 2000-08-14
DK0981527T3 (da) 2003-09-01
US20110312987A1 (en) 2011-12-22
CZ288673B6 (cs) 2001-08-15
UA56218C2 (uk) 2003-05-15
US20130065917A1 (en) 2013-03-14
NO312515B1 (no) 2002-05-21
NO994595D0 (no) 1999-09-21
ID22681A (id) 1999-12-09
IS5181A (is) 1999-09-14
SI0981527T1 (en) 2003-10-31
DE69814378D1 (de) 2003-06-12
SK284107B6 (sk) 2004-09-08
ATE239724T1 (de) 2003-05-15
PL335812A1 (en) 2000-05-22
EP0981527A1 (de) 2000-03-01
ES2213669T3 (es) 2004-09-01
AU726634B2 (en) 2000-11-16
JP2000510484A (ja) 2000-08-15
CZ288715B6 (cs) 2001-08-15
CN1251101A (zh) 2000-04-19
HK1026698A1 (en) 2000-12-22
IS7952A (is) 2005-07-21
TR199902313T2 (xx) 1999-12-21
PT1179533E (pt) 2004-05-31
JP2004002413A (ja) 2004-01-08
PT981527E (pt) 2003-09-30
HUP0600401A3 (en) 2010-05-28
NO994595L (no) 1999-09-21
NZ337748A (en) 2001-03-30
DE69814378T2 (de) 2004-02-26
AU6636698A (en) 1998-10-20
AP9901649A0 (en) 1999-09-30
BG63972B1 (bg) 2003-08-29
MA24500A1 (fr) 1998-10-01
HU225412B1 (en) 2006-11-28
OA11161A (en) 2003-04-25
KR100266499B1 (ko) 2000-12-01
US20150291585A1 (en) 2015-10-15
AR012125A1 (es) 2000-09-27
IS2095B (is) 2006-04-12
IL131812A0 (en) 2001-03-19
EA001674B1 (ru) 2001-06-25
PE67999A1 (es) 1999-09-30
US20090182006A1 (en) 2009-07-16
CN1131229C (zh) 2003-12-17
US20080039488A1 (en) 2008-02-14
US20170253588A1 (en) 2017-09-07
US20160264569A1 (en) 2016-09-15
IL131812A (en) 2006-04-10
DE69821147D1 (de) 2004-02-19
BG103750A (en) 2000-06-30
IN188178B (de) 2002-08-31
AP1331A (en) 2004-11-26
DK1179533T3 (da) 2004-05-03
CA2283671C (en) 2003-09-16
US20140187576A1 (en) 2014-07-03
CZ328299A3 (cs) 2000-02-16
MY137653A (en) 2009-02-27

Similar Documents

Publication Publication Date Title
DZ2448A1 (fr) Sel du dérivé d'acide de naphthyridine carboxylique.
DZ2800A1 (fr) Nouveau dérivé de l'acide 3-aryl-2-hydroxypropionique.
HK1043124A1 (en) Salt of naphthyridine carboxylic acid derivative.
ATE228995T1 (de) Aminomethylcarbonsäurederivate
EE04281B1 (et) 8-metoksükinoloonkarboksüülhapete valmistamismeetod
NO921840D0 (no) Substituerte karboksylsyrederivater
DK1114023T3 (da) Fremgangsmåde til fremstilling af carboxylsyrer
DE69133019D1 (de) Imidazolyl-alkencarbonsäuren
FI963050A (fi) Menetelmä klavulaanihapposuolan valmistamiseksi
FI960634A0 (fi) Uusia kinolonikarboksyylihappojohdannaisia
FR2791673B1 (fr) Procede de preparation des esters de l'acide hydroxymethylthiobutyrique
IS5009A (is) 3-Alkoxýísoxazól-4-ýl setin 2-amínó karboxýlsýru efnasambönd
NO20001777L (no) Fremgangsmate for fremstilling av substituerte 4-fenyl-4-cyanocykloheksankarboksylsyrer
FI942581A (fi) Menetelmä 5-bromi-6-metoksi-1-naftoehappometyyliesterin valmistamiseksi
NO940623L (no) Fremgangsmåte for fremstilling av karboksylsyreanhydrider
NO308465B1 (no) FremgangsmÕte for fremstilling av karboksylsyrederivater
DE69305714D1 (de) Abspaltbare Carbonsäuren
NO995388D0 (no) Fremgangsmåte for fremstilling av formylfosfonsyre
MA23133A1 (fr) Derives d'acide d'acyloxyhexanoique .
BR9610139A (pt) Derivado de ácido carboxílico
FR2769624B1 (fr) Procede de preparation d'acide carboxylique
PT1133495E (pt) Semi-hidrocloreto do acido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo-¬4.3.0|-nonano-8-il)-6-fluoro-1,4-diidro-4-oxo-3-quinolinocarboxilico
AU3076295A (en) Heterocyclyl-1-phenyl substituted quinolone carboxylic acids as antiviral agents
FR2791668B1 (fr) Procede de preparation d' beta-hydroxy acides
GB9907082D0 (en) The preparation of carboxylic acid derivatives